Volume 3, Issue 11: Highlights from the 2014 EASL Meeting

e-Viral Hepatitis Review is a monthly CE series for nurses, nurse practitioners, and others involved in the care of patients with Hepatitis. It provides updates on the latest research, best practices, and issues currently under debate, as well as a concise review of relevant journal literature.

 

(Volume 3, Issue 11)

Target Audience

Nurses and health care professionals involved in the care of patients with Hepatitis.

Learning Objectives

After participating in this activity, the participant will demonstrate the ability to: 

  • Summarize recently released data about noninterferon-containing regimens for treating hepatitis C.
  • Describe any performance gaps for interferon-free regimens in patients with cirrhosis.
  • Describe the role of ribavirin as a component of HCV treatment in new interferon-free regimens.
  • Describe newly presented information about noninvasive markers of liver disease.
Additional information
Contact email: 
ijhn@jhmi.edu
Course summary
Available credit: 
  • 0.50 ANCC
  • 0.50 Attendance
Registration opens: 
06/30/2014
Registration closes: 
06/29/2016
Cost:
$0.00
Mark S. Sulkowski, MD
Professor of Medicine
Medical Director, Viral Hepatitis Center
Divisions of Infectious Diseases and Gastroenterology/Hepatology
The Johns Hopkins University School of Medicine
Baltimore, Maryland
 
Raymond T. Chung, MD
Associate Director of Medicine
Harvard Medical School
Director of Hepatology
Vice Chief of Gastroenterology
Massachusetts General Hospital
Boston, Massachusetts
 
Laurent Castera, MD, PhD
Department of Hepatology
Beaujon Hospital, AP-HP
INSERM U773
University of Paris-Diderot
Clichy, France

 

Available Credit

  • 0.50 ANCC
  • 0.50 Attendance

Price

Cost:
$0.00
Please login or register to take this course.

Required Hardware/software

Make sure your Adobe flash is updated by clicking HERE.